Literature DB >> 8357123

Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1.

P M Ridker, C O'Donnell, V J Marder, C H Hennekens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8357123     DOI： 10.7326/0003-4819-119-6-199309150-00017

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  11 in total

1.  Intravenous beta blockade in acute myocardial infarction. Should be used in combination with thrombolysis.

Authors:  A Owen
Journal:  BMJ       Date:  1998-07-25

Review 2.  Fortnightly review: anticoagulation in heart disease.

Authors:  S M Hardman; M R Cowie
Journal:  BMJ       Date:  1999-01-23

3.  Implications of the GUSTO trial for thrombolytic therapy.

Authors:  F Van de Werf
Journal:  Drugs       Date:  1996-09       Impact factor: 9.546

4.  Medical newsletters: funding and interests should be stated.

Authors:  J M Brophy
Journal:  CMAJ       Date:  1995-06-01       Impact factor: 8.262

Review 5.  Alteplase: a pharmacoeconomic evaluation of its use in the management of myocardial infarction.

Authors:  L B Barradell; K L Goa
Journal:  Pharmacoeconomics       Date:  1995-11       Impact factor: 4.981

6.  Direct Comparison of Aspirin Plus Hirudin, Aspirin Plus Heparin, and Aspirin Alone Among 12,000 Patients with Acute Myocardial Infarction Not Receiving Thrombolysis: Rationale and Design of the First American Study of Infarct Survival (ASIS-1).

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

7.  Efficacy and safety of a new streptokinase regimen with enoxaparin in acute myocardial infarction.

Authors:  Gabriel Tatu-Chitoiu; Cristina Teodorescu; Monica Dan; Petre Capraru; Manuela Guran; Oana Istratescu; Alexandrina Tatu-Chitoiu; Aurelia Bumbu; Maria Dorobantu
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

8.  A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction.

Authors:  S C Kalish; J H Gurwitz; H M Krumholz; J Avorn
Journal:  J Gen Intern Med       Date:  1995-06       Impact factor: 5.128

9.  Streptokinase versus alteplase in acute myocardial infarction.

Authors:  H S Friedman
Journal:  J R Soc Med       Date:  1996-08       Impact factor: 18.000

Review 10.  Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement.

Authors:  Victor Gurewich
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.